Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01751646 · ClinicalTrials.gov registry record · NA
Vitamin D Absorption in HIV Infected Young Adults Being Treated With Tenofovir Containing cART
A NA study, sponsored by University of North Carolina, Chapel Hill.
- Completed
- Registry status
- NA
- Development phase
- 214
- Enrollment target
NCT01751646 is a NA study that has completed, run by University of North Carolina, Chapel Hill. The registered enrollment target is 214 participants.
The verdict
NCT01751646, a NA study, has completed, sponsored by University of North Carolina, Chapel Hill.
- COMPLETED
- Registry status
- NA
- Development phase
- 214 participants
- Enrollment target
Study Summary
This is a 48 week randomized double-blind, placebo-controlled prospective cohort study of adolescents and young adults with HIV infection in the Adolescent Medicine Trials Network for HIV/AIDS Interventions (ATN) who are currently being treated with cART that includes tenofovir disoproxil fumarate (TDF) as one component of the regimen that includes at least three Food and Drug Administration (FDA)-approved antiretroviral (ARV) drugs for at least 180 days.
Interventions
- DIETARY_SUPPLEMENT Vitamin D3 placebo
- DIETARY_SUPPLEMENT Vitamin D3 50,000 IU
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 214 participants |
| Start Date | 2012-10 |
| Est. Completion | 2016-06 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01751646
The ClinicalTrials.gov registry entry for NCT01751646 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 214 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of North Carolina, Chapel Hill, which has 1,109 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Vitamin D3 placebo is the first listed.
NCT01751646 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01751646 about?
NCT01751646 is a clinical study titled "Vitamin D Absorption in HIV Infected Young Adults Being Treated With Tenofovir Containing cART". This is a 48 week randomized double-blind, placebo-controlled prospective cohort study of adolescents and young adults with HIV infection in the Adolescent Medicine Trials Network for HIV/AIDS Interventions (ATN) who are currently being treated with cART that includes tenofovir disoproxil fumarate (...
What is the current status of trial NCT01751646?
This trial is currently completed. It is a NA study. The enrollment target is 214 participants. The study started on 2012-10. Estimated completion is 2016-06.
What interventions are being tested in trial NCT01751646?
The interventions under investigation include: Vitamin D3 placebo (DIETARY_SUPPLEMENT), Vitamin D3 50,000 IU (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT01751646?
This trial is sponsored by University of North Carolina, Chapel Hill, which has 1,109 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.